Cytopathological diagnosis of visceral histiocytic sarcoma in five dogs

• Autorzy: Sapierzynski R. , Jagielski D. , Dolka I. , Fabisiak M.
• Języki publikacji: EN

Abstrakty

EN

Histiocytic sarcoma is a malignant neoplastic proliferation of atypical histiocytes with tendency to spread, characterized by fast progression to disseminated form - disseminated histiocytic sarcoma. Cytopathology is a low, invasive, cheap, and quick method of diagnosis commonly used in veterinary oncology. The aim of the presented study was description of cases of visceral histiocytic sarcomas in dogs diagnosed by cytopathology and immunocytochemistry. The study was conducted on 5 dogs which were brought to the veterinary clinic because of unspecific clinical signs and tumoral masses recognized in the thoracic or abdominal cavity. Samples of cells were collected during ultrasonography- assisted fine-needle aspiration biopsy (FNAB), smears were stained with Giemsa method and immunocytochemistry (CD3, CD79α, cytokeratin, vimentin, desmin) was also performed in all patients. Four of five dogs were Bernese mountain dogs, nonspecific clinical signs of systemic disease were present in all cases. Visceral mass or masses were detected by ultrasonography or radiography. Final diagnosis of histiocytic sarcoma was obtained on the basis of routine cytopathological examination and confirmed by immunocytochemistry. On the basis the results obtained it can be stated that in cases of typical clinical and cytopathologic pictures, examination of cellular samples collected during ultrasonography-assisted fine-needle biopsy supported by some immunocytopathological characteristics seems to be sufficient method of diagnosis of histiocytic sarcoma in dogs. Visceral histiocytic sarcoma should be included into differential diagnosis in every Bernese mountain dog with nonspecific clinical signs, ambiguous results of hematologic examination and when tumoral mass or masses within a body cavity were detected in imaging techniques.

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2012
• Tom: 15
• Numer: 4
• Opis fizyczny: p.751-758,fig.,ref.

Twórcy

autor

Sapierzynski R.

• Department of Pathology and Veterinary Diagnostic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Nowoursynowska 159c, 02-766 Warsaw, Poland

autor

Jagielski D.

• Veterinary Surgery Białobrzeska in Warsaw, Poland

autor

Dolka I.

• Department of Pathology and Veterinary Diagnostic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Nowoursynowska 159c, 02-766 Warsaw, Poland

autor

Fabisiak M.

• Department of Pathology and Veterinary Diagnostic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Nowoursynowska 159c, 02-766 Warsaw, Poland

Bibliografia

• Abadie J, Hedan B, Cadieu E, de Brito C, Devauchelle P, Bourgain C, Parker HG, Vaysse A, Margaritte-Jeannin P, Galibert F, Ostrander EA, Andre C (2009) Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese mountain dog breed. J Hered: S19-S27.
• Affolter VK, Moore PF (2002) Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Vet Pathol 39: 74-83.
• Baker R, Lumsden J (2000) The skin. In: Baker R, Lumsden J (eds) Colour Atlas of Cytology of the Dog and Cat. Mosby, St. Louis, pp 39-70.
• Constantino-Casas F, Mayhew D, Hoather TM, Dobson JM (2011) The clinical presentation and histopathologic-immunohistochemical classification of histiocytic sarcomas in the Flat Coated Retriever. Vet Pathol 48: 764-771.
• Frasik W, Ingarden M, Ingarden J, Jasztal A (2007) Malignant histiocytosis in Bernese mountain dog – case description. Magazyn Weterynaryjny 16: 36-39.
• Ide T, Uchida K, Kagawa Y, Suzuki K, Nakayama H (2011) Pathological and immunohistochemical features of subdural histiocytic sarcomas in 15 dogs. J Vet Diagn Invest 23: 127-132.
• Moore PF (1986) Utilization of cytoplasmic lysozyme immunoreactivity as a histiocytic marker in canine histiocytic disorders. Vet Pathol 23: 757-762.
• Newlands CE, Houston DM, Vasconcelos DY (1994) Hyperferritinemia associated with malignant histiocytosis in a dog. J Am Vet Med Assoc 205: 849-851.
• Nielsen LN, McEvoy F, Jessen LR, Kristensen AT (2011) Investigation of a screening programme and the possible identification of biomarkers for early disseminated histiocytic sarcoma in Bernese Mountain dogs. Vet Comp Oncol 10: 124-134.
• Padgett GA, Madewell BR, Keller ET, Jodar L, Packard M (1995) Inheritance of histiocytosis in Bernese mountain dogs. J Small Anim Pract 36: 93-98.
• Paterson S, Boydell P, Pike R (1995) Systemic histiocytosis in the Bernense mountain dog. J Small Anim Pract 36: 233-236.
• Ramsey IK, McKay JS, Rudorf H, Dobson JM (1996) Malignant histiocytosis in three Bernese mountain dogs. Vet Rec 138: 440-444.
• Sapierzyński R (2010) Practical aspects of immunocytochemistry in canine lymphomas. Pol J Vet Sci13: 661-668.
• Soare T, Noble PJ, Hetzel U, Fonfara S, Kipar A (2012) Paraneoplastic syndrome in haemophagocytic histiocytic sarcoma in a dog. J Comp Pathol 146: 168-174.
• Tzipory L, Vernau KM, Sturges BK, Zabka TS, Highland MA, Petersen SA, Wisner ER, Moore PF, Vernau W (2009) Antemortem diagnosis of localized central nervous system histiocytic sarcoma in 2 dogs. J Vet Intern Med 23: 369-374.
• Vail DM (2007) Histiocytic disorders. In: Withrow SJ, McEwen EG (eds) Small Animal Clinical Oncology, 3th ed., WB Saunders Company, Philadelphia, pp 667-671

Uwagi

rekord w opracowaniu